Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study - Concepedia

Concepedia

Publication | Open Access

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

DOI Full Paper Access

71

Citations

21

References

2023

Year

Ignace Vergote, Els Van Nieuwenhuysen, Roisin E. O’Cearbhaill, Anneke M. Westermann, Domenica Lorusso, Sharad Ghamande, Dearbhaile Catherine Collins, Susana Banerjee, Cara Mathews, Christine Gennigens,

Journal of Clinical Oncology

Abstract

TV in combination with bevacizumab, carboplatin, or pembrolizumab demonstrated manageable safety and encouraging antitumor activity in treatment-naive and previously treated r/mCC.

References

	Year	Citations

Page 1